Galapagos | GLPG - Operating Expenses


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Galapagos

Galapagos reported EUR165.2M in Operating Expenses for its fiscal quarter ending in March of 2023.


Operating Expenses Change
AstraZeneca AZN:LN USD 8.33B 1.78B
Biogen BIIB:US USD 1.96B 111.2M
Genmab GEN:DC DKK 2.42B 145M
Gilead Sciences GILD:US USD 4.65B 475M
GlaxoSmithKline GSK:LN GBP 4.87B 640M
Hikma Pharmaceutical HIK:LN USD 1.24B 280M
Incyte Corp INCY:US USD 783.9M 72.7M
Neurocrine Biosciences NBIX:US USD 534.6M 226M
Novartis NOVN:VX USD 10.35B 700M
Roche Holding ROG:VX CHF 25.06B 4.31B
UCB UCB:BB EUR 2.5B 62M
Vertex Pharmaceuticals VRTX:US USD 1.6B 326.6M